These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


82 related items for PubMed ID: 20127018

  • 1. Multiplex genotyping of 1107 SNPs from 232 candidate genes identified an association between IL1A polymorphism and breast cancer risk.
    Han W, Kang SY, Kang D, Park SK, Lee JY, Kim H, Park AK, Noh DY.
    Oncol Rep; 2010 Mar; 23(3):763-9. PubMed ID: 20127018
    [Abstract] [Full Text] [Related]

  • 2. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
    Singh V, Rastogi N, Sinha A, Kumar A, Mathur N, Singh MP.
    Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
    [Abstract] [Full Text] [Related]

  • 3. A haplotype analysis of HER-2 gene polymorphisms: association with breast cancer risk, HER-2 protein expression in the tumor, and disease recurrence in Korea.
    Han W, Kang D, Lee JE, Park IA, Choi JY, Lee KM, Bae JY, Kim S, Shin ES, Lee JE, Shin HJ, Kim SW, Kim SW, Noh DY.
    Clin Cancer Res; 2005 Jul 01; 11(13):4775-8. PubMed ID: 16000574
    [Abstract] [Full Text] [Related]

  • 4. Large-scale evaluation of genetic variants in candidate genes for colorectal cancer risk in the Nurses' Health Study and the Health Professionals' Follow-up Study.
    Hazra A, Chanock S, Giovannucci E, Cox DG, Niu T, Fuchs C, Willett WC, Hunter DJ.
    Cancer Epidemiol Biomarkers Prev; 2008 Feb 01; 17(2):311-9. PubMed ID: 18268114
    [Abstract] [Full Text] [Related]

  • 5. Progesterone receptor polymorphisms and risk of breast cancer: results from two Australian breast cancer studies.
    Johnatty SE, Spurdle AB, Beesley J, Chen X, Hopper JL, Duffy DL, Chenevix-Trench G, Kathleen Cuningham Consortium for Research in Familial Breast Cancer.
    Breast Cancer Res Treat; 2008 May 01; 109(1):91-9. PubMed ID: 17592773
    [Abstract] [Full Text] [Related]

  • 6. Vitamin D pathway gene polymorphisms, diet, and risk of postmenopausal breast cancer: a nested case-control study.
    McCullough ML, Stevens VL, Diver WR, Feigelson HS, Rodriguez C, Bostick RM, Thun MJ, Calle EE.
    Breast Cancer Res; 2007 May 01; 9(1):R9. PubMed ID: 17244366
    [Abstract] [Full Text] [Related]

  • 7. Clarifying the PROGINS allele association in ovarian and breast cancer risk: a haplotype-based analysis.
    Pearce CL, Hirschhorn JN, Wu AH, Burtt NP, Stram DO, Young S, Kolonel LN, Henderson BE, Altshuler D, Pike MC.
    J Natl Cancer Inst; 2005 Jan 05; 97(1):51-9. PubMed ID: 15632380
    [Abstract] [Full Text] [Related]

  • 8. Genetic polymorphisms of SULT1A1 and SULT1E1 and the risk and survival of breast cancer.
    Choi JY, Lee KM, Park SK, Noh DY, Ahn SH, Chung HW, Han W, Kim JS, Shin SG, Jang IJ, Yoo KY, Hirvonen A, Kang D.
    Cancer Epidemiol Biomarkers Prev; 2005 May 05; 14(5):1090-5. PubMed ID: 15894657
    [Abstract] [Full Text] [Related]

  • 9. Association of polymorphisms and haplotypes in the human growth hormone 1 (GH1) gene with breast cancer.
    Wagner K, Hemminki K, Israelsson E, Grzybowska E, Klaes R, Chen B, Butkiewicz D, Pamula J, Pekala W, Försti A.
    Endocr Relat Cancer; 2005 Dec 05; 12(4):917-28. PubMed ID: 16322331
    [Abstract] [Full Text] [Related]

  • 10. Common variation in BRCA2 and breast cancer risk: a haplotype-based analysis in the Multiethnic Cohort.
    Freedman ML, Penney KL, Stram DO, Le Marchand L, Hirschhorn JN, Kolonel LN, Altshuler D, Henderson BE, Haiman CA.
    Hum Mol Genet; 2004 Oct 15; 13(20):2431-41. PubMed ID: 15317758
    [Abstract] [Full Text] [Related]

  • 11. Association of IL1A, IL1B, and TNF gene polymorphisms with chronic rhinosinusitis with and without nasal polyposis: A replication study.
    Mfuna Endam L, Cormier C, Bossé Y, Filali-Mouhim A, Desrosiers M.
    Arch Otolaryngol Head Neck Surg; 2010 Feb 15; 136(2):187-92. PubMed ID: 20157068
    [Abstract] [Full Text] [Related]

  • 12. A comprehensive haplotype analysis of CYP19 and breast cancer risk: the Multiethnic Cohort.
    Haiman CA, Stram DO, Pike MC, Kolonel LN, Burtt NP, Altshuler D, Hirschhorn J, Henderson BE.
    Hum Mol Genet; 2003 Oct 15; 12(20):2679-92. PubMed ID: 12944421
    [Abstract] [Full Text] [Related]

  • 13. Genetic variants in epigenetic genes and breast cancer risk.
    Cebrian A, Pharoah PD, Ahmed S, Ropero S, Fraga MF, Smith PL, Conroy D, Luben R, Perkins B, Easton DF, Dunning AM, Esteller M, Ponder BA.
    Carcinogenesis; 2006 Aug 15; 27(8):1661-9. PubMed ID: 16501248
    [Abstract] [Full Text] [Related]

  • 14. ERCC4 associated with breast cancer risk: a two-stage case-control study using high-throughput genotyping.
    Milne RL, Ribas G, González-Neira A, Fagerholm R, Salas A, González E, Dopazo J, Nevanlinna H, Robledo M, Benítez J.
    Cancer Res; 2006 Oct 01; 66(19):9420-7. PubMed ID: 17018596
    [Abstract] [Full Text] [Related]

  • 15. Polymorphisms in nonhomologous end-joining genes associated with breast cancer risk and chromosomal radiosensitivity.
    Willems P, Claes K, Baeyens A, Vandersickel V, Werbrouck J, De Ruyck K, Poppe B, Van den Broecke R, Makar A, Marras E, Perletti G, Thierens H, Vral A.
    Genes Chromosomes Cancer; 2008 Feb 01; 47(2):137-48. PubMed ID: 18000863
    [Abstract] [Full Text] [Related]

  • 16. Polymorphisms in the Janus kinase 2 (JAK)/signal transducer and activator of transcription (STAT) genes: putative association of the STAT gene region with familial breast cancer.
    Vaclavicek A, Bermejo JL, Schmutzler RK, Sutter C, Wappenschmidt B, Meindl A, Kiechle M, Arnold N, Weber BH, Niederacher D, Burwinkel B, Bartram CR, Hemminki K, Försti A.
    Endocr Relat Cancer; 2007 Jun 01; 14(2):267-77. PubMed ID: 17639043
    [Abstract] [Full Text] [Related]

  • 17. A role for XRCC4 in age at diagnosis and breast cancer risk.
    Allen-Brady K, Cannon-Albright LA, Neuhausen SL, Camp NJ.
    Cancer Epidemiol Biomarkers Prev; 2006 Jul 01; 15(7):1306-10. PubMed ID: 16835328
    [Abstract] [Full Text] [Related]

  • 18. Folate intake, methylenetetrahydrofolate reductase polymorphisms, and breast cancer risk in women from the Malmö Diet and Cancer cohort.
    Ericson U, Sonestedt E, Ivarsson MI, Gullberg B, Carlson J, Olsson H, Wirfält E.
    Cancer Epidemiol Biomarkers Prev; 2009 Apr 01; 18(4):1101-10. PubMed ID: 19336565
    [Abstract] [Full Text] [Related]

  • 19. Genetic variation in TP53 and risk of breast cancer in a population-based case control study.
    Sprague BL, Trentham-Dietz A, Garcia-Closas M, Newcomb PA, Titus-Ernstoff L, Hampton JM, Chanock SJ, Haines JL, Egan KM.
    Carcinogenesis; 2007 Aug 01; 28(8):1680-6. PubMed ID: 17449902
    [Abstract] [Full Text] [Related]

  • 20. Association of common PALB2 polymorphisms with breast cancer risk: a case-control study.
    Chen P, Liang J, Wang Z, Zhou X, Chen L, Li M, Xie D, Hu Z, Shen H, Wang H.
    Clin Cancer Res; 2008 Sep 15; 14(18):5931-7. PubMed ID: 18794107
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.